Search

PerkinElmer Inc

Fechado

SetorSaúde

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

13M

53M

Vendas

19M

730M

P/E

Médio do Setor

56.121

57.371

EPS

1.41

Rendimento de Dividendos

0.24

Margem de lucro

7.329

Funcionários

11,000

EBITDA

8.8M

189M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

-6.56% downside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

0.24%

2.23%

Próximos Ganhos

26 de out. de 2026

Próxima data de dividendos

13 de nov. de 2026

Próxima data de ex-dividendo

23 de out. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

109M

13B

Abertura anterior

0

Fecho anterior

0

Sentimento de Notícias

By Acuity

10%

90%

17 / 340 Ranking em Healthcare

PerkinElmer Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de ago. de 2026, 23:51 UTC

Revvity Inc shares are trading lower in after-market hours. The decline follows a consistent downward trend since Friday's close, despite remaining above the 20-day moving average.

20 de ago. de 2026, 22:01 UTC

Revvity Inc shares are lower in after-market trading, continuing a decline since Thursday's close, despite being above its 20-day moving average.

19 de ago. de 2026, 23:11 UTC

Revvity Inc shares are higher in after-market trading, maintaining gains above the 20-day moving average and near the top of their one-month range.

17 de ago. de 2026, 19:46 UTC

News

RVTY shares lower after analyst downgrades from JPMorgan, Stifel.

14 de ago. de 2026, 20:13 UTC

Revvity Inc shares are lower in after-market trading, with no specific news driving the decline. Broader market trends include a drop in U.S. retail sales.

13 de ago. de 2026, 19:46 UTC

News

Revvity shares are lower despite Q2 revenue and non-GAAP earnings growth. Analysts raised concerns about segment dynamics and competitive challenges following the earnings report.

12 de ago. de 2026, 19:46 UTC

Revvity Inc shares are higher today, supported by positive market sentiment following a favorable inflation report and strong quarterly results from technology companies.

11 de ago. de 2026, 20:13 UTC

Revvity Inc. shares are trading roughly flat after-market hours, with market sentiment influenced by expectations for the upcoming Consumer Price Index report.

10 de ago. de 2026, 22:01 UTC

Revvity Inc shares are trading higher in after-market hours, following broader market dynamics and reduced expectations for Federal Reserve rate hikes.

7 de ago. de 2026, 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6 de ago. de 2026, 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5 de ago. de 2026, 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4 de ago. de 2026, 19:51 UTC

Social Media
News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

3 de ago. de 2026, 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

31 de jul. de 2026, 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

29 de jul. de 2026, 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

28 de jul. de 2026, 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

27 de jul. de 2026, 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

22 de jul. de 2026, 18:51 UTC

Revvity Inc shares are higher since Tuesday's close amid broader market gains, influenced by rising crude oil prices from geopolitical tensions involving the U.S. and Iran.

21 de jul. de 2026, 20:02 UTC

Revvity Inc shares are higher, supported by renewed interest in AI stocks and anticipation of earnings from major companies like Alphabet and Tesla.

20 de jul. de 2026, 19:21 UTC

News

Revvity Inc. published its 2026 Impact Report, disclosing Scope 3 emissions. Shares are lower amid broader industry challenges and a cautious analyst outlook.

Comparação entre Pares

Variação de preço

PerkinElmer Inc Previsão

Preço-alvo

By TipRanks

-6.56% parte inferior

Previsão para 12 meses

Média 116.57 USD  -6.56%

Máximo 130 USD

Mínimo 110 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para PerkinElmer Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

9 ratings

3

Comprar

6

Manter

0

Vender

Sentimento

By Acuity

17 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat